The head of the panel of 18 appointees, known as STIKO, said there was no clear case for broad use, citing a lack of data to rule out any rare side effects and no signs of the infection causing severe illness in otherwise healthy children.
Narayana Murthy said in his speech announcing the winners of the Infosys Science Prize that the IITs have become victims of the syndrome of rote learning due to the tyranny of coaching classes.
China’s National Medical Products Administration approved CanSino’s Ad5-nCoV for emergency use as a booster vaccine, the company said in a statement to the Hong Kong Stock Exchange on Sunday.
Meghalaya has the worst 8 percent coverage of the Covid booster dose among its eligible population, while Andhra Pradesh has the highest at 34 percent
Production delays, probes by regulators following rare cases of severe side effects, and concerns about its relatively short shelf life compared with other shots have stymied adoption of the company's COVID-19 vaccine.
Recalling an incident in the US, External Affairs Minister S Jaishankar said, "There, they wanted to see our Covid vaccination certificate. So, I showed them my phone while my son...
With Bharat Biotech completing clinical trials of its vaccine candidate, hopes have been raised about the availability of intranasal vaccine as a booster dose just as the number of daily Covid-19 cases and test positivity rate in parts of India have started surging over the last few weeks.
The Indian Medical Association (IMA) claimed that a smear campaign was being run in the nation against the vaccination push and modern medicines, and the Supreme Court consented to hear their case next week.
According to official sources, a government commission on Covid immunisation has advised enabling people who have received the complete course of either Covishield or Covaxin vaccination to take Biological E's Corbevax as a precautionary dose.
The findings of the study have been published in the high-impact scientific journal Nature.
"Congratulations Narendra Modi for yet another milestone of administering #200crorevaccinations," wrote Bill Gates on Twitter.
The number of tests conducted so far exceeds 86 crore 90 lakh, among which over four lakh 17 thousand tests were conducted in the last 24 hours.
The Union health ministry holds a meeting with states on July 14 to review the status of COVID-19 vaccination and offer free boosters to all adults in a mission mode
Last year, the Union government had paid an advance of Rs 1,500 crore to Corbevax maker Biological E to procure 30 crore doses of the vaccine, which was still in phase 3 clinical trials, in the first such deal to secure a vaccine.
Our specially curated package of the most interesting articles to help you stay at the top of your game.
India has reported a significant spike in the COVID-19 cases as it reported 17,336 new cases of virus in the last 24 hours as compared to the 13,313 total cases recorded on June 23, the Union Health Ministry informed.
People at high risk will continue to be at some level of risk, even if they are vaccinated or previously infected. Vaccination and prior infection reduce the risk but do not completely remove the chances of getting infected again, says one of India’s leading microbiologists and virologists.
This is a remarkable feat, considering that all the vaccine doses administered in the country are made locally
The company said that no adverse events of special interest have been reported to date. However, a supplementary surveillance study is going on, which will provide more information on rarer adverse events
The pharma regulator has approved the first mix-and-match of COVID-19 vaccines in India, but the final say-so lies with the government
In 27 states, the coverage of precaution dose among 60 years and above is below the national average of 42 per cent.
The way things are going, they’ll soon take the blame for global warming or for the inequitable distribution of vaccines...
Stelis Biopharma, the biopharmaceutical arm of Strides Pharma Science, said it could not sell 2.5 crore units of the single-dose vaccine manufactured by it due to several constraints following the Russian-Ukraine war.
An official announcement was made by Health Minister Mansukh Mandaviya on Twitter.
Currently, anyone over the age of 18 who has completed nine months since the second dose is eligible for the precaution dose.